Shuki Nir succeeds Ronen Faier, who will serve as interim CEO from August 2024.
Lowental Crossbreed was developed in 2018 by bros and sis ITAY and Netta Lowental.
Nurami has actually created items for neurological surgical procedure, particularly targeting cerebrospinal liquid leak.
These incorrect agreements led to Promai investing 20 million Shekels ($5.38 million) that were never ever purchased.
The business maintains staff members cost free and deals with financial debt.
The system determines components created by AI, spots procedures and confirms message precision.
Sign in to your account